Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes

Cancer Research

Volumn 69, Issue 5, 2009, Pages 2091-2099

  Li, Aiguo ^a   Walling, Jennifer ^a   Ahn, Susie ^a   Kotliarov, Yuri ^a   Su, Qin ^a   Quezado, Martha ^b   Oberholtzer, J Carl ^b   Park, John ^c   Zenklusen, Jean C ^a   Fine, Howard A ^a,d  

^a Neuro Oncology Branch   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MACHINE LEARNING; OLIGODENDROGLIOMA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; TRANSCRIPTOMICS; TUMOR CLASSIFICATION; VALIDATION PROCESS; ADULT; BRAIN TUMOR; CLASSIFICATION; GENETICS; GLIOMA; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; BRAIN NEOPLASMS; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; MIDDLE AGED;

EID: 62449321780     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2100     Document Type: Article

References (25)

1. Cancer Statistics Branch N, NIH. Cancer Survival rates. In: Harras A, editor. Cancer: Rates & Risks. Washington (DC). US Dept of Health & Human Services, National Institutes of Health; 1996. p. 28-34.
2. Godard S, Getz G, Delorenzi M1 et al. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 2003;63:6613-6625
3. Shai R, Shi T, Křemen TJ, et al. Gene expression, profiling identifies molecular subtypes of gliomas. Oncogene 2003;22:4918-4923
4. Louis DN, Ohgaki H, Wlestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Beri) 2007;114:97-109.
5. Ohgaki H1 Dessen P1 Jourde B1 et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004;64:6892-6899
6. Kitange GJ, Templeton KL, Jenkins RB. Recent advances in the molecular genetics of primary gliomas. Curr Opta Oncol 2003:15:1.97-203.
7. Rich JN, Bigner DD. Development of novel targeted therapies in. the treatment of malignant glioma. Nat Rev 2004;3:430-446
8. Rich JN, Hans C, Jones B, et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 2005;65:4051-4058
9. Okada Y, Hurwitz EE, Esposito JM1 Brower MA1 Nutt CL1 Louis DN. Selection pressures of TP53 mutation, and microenvironmental location Influence epidermal growth factor receptor gene amplification in human, glioblastomas. Cancer Res 2003;63:413-416
10. Coons SW, Johnson PC, Schelthauer BW, Yates AJ, Pearl DK Improving diagnostic accuracy and inter-observer concordance in the classification and grading of primary gliomas. Cancer 1997:79:1381-1393
11. Liang Y, Diehn M, Watson N, et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sei USA 2005;102:5814-5819
12. Golub TR, Sloním DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction, by gene expression, monitoring. Science 1999;286:531-537
13. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade gUoma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006;9:157-173
14. Mischel PS, Shai R, Shi T, et al. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 2003:22:2361-2373
15. Nutt CL, Betensky RA, Brower MA, Batchelor TT, Louis DN, Stemmer-Rachamimov AO. YK.L-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas. Clin Cancer Res 2005;11:2258-2264
16. Nigra JM, Misra A, Zhang L, et al. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of gUoblastoma Cancer Res 2005:65:1678-1686
17. T'so CL, Shintaku. P1 Chen. J1 et al. Primary glioblas-tomas express mesenchymal stem-like properties. MoI Cancer Res 2006;4:607-619
18. Miller CL, Dlglisic S1 Leister F1 Webster M1 Yolken RH. Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue. Biotechniques 2004:36: 628-633
19. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ. High density synthetic oligonucleotide arrays. Nat Genet 1999;21:20-24
20. Brunet JP, Tamayo P, Golúb TR, MesirovJP. Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad. Sei U S A 2004:101:4164-4169
21. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sd U S A 2002;99:6567-6572
22. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sei U S A 2005:102:15545-15550
23. McLendon R, Friedman A, Blgner D1 et al. Compre-hensive genomic characterization defines huirían glio-blastoma genes and core pathways. Nature 2008:455: 1061-8.
24. Freije WA, Castro-Vargas FE, Fang Z, et al. Gene expression, profiling of gliomas strongly predicts survival. Cancer Res 2004;64:6503-6510
25. Kotliarov Y, Steed ME, Christopher N, et al. High-resolution global, genomic survey of 1.78 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res 2006;66:9428-9436